ArticleCancer gene therapy2014
Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3.
R Gan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this papercites it